Avidity Biosciences Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -322,302 | -212,220 | -173,995 | -118,009 | -44,355 |
| Depreciation Amortization | -18,671 | -9,173 | 772 | 818 | 382 |
| Other Working Capital | -14,557 | 61,129 | 7,067 | 4,643 | 2,332 |
| Other Operating Activity | 54,660 | 41,200 | 29,888 | 17,735 | 4,524 |
| Operating Cash Flow | $-300,870 | $-119,064 | $-136,268 | $-94,813 | $-37,117 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -847,135 | -125,842 | -187,132 | -78,777 | -6,693 |
| PPE Investments | -7,066 | -4,228 | -2,823 | -3,740 | -1,092 |
| Investing Cash Flow | $-854,201 | $-130,070 | $-189,955 | $-82,517 | $-7,785 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -4,683 |
| Common Stock Issued | 1,192,357 | 93,864 | 346,171 | 176,316 | 274,520 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 2,200 |
| Financing Cash Flow | $1,192,357 | $93,864 | $346,171 | $176,316 | $272,037 |
| Beginning Cash Position | 185,377 | 340,647 | 320,699 | 321,713 | 94,578 |
| End Cash Position | 222,663 | 185,377 | 340,647 | 320,699 | 321,713 |
| Net Cash Flow | $37,286 | $-155,270 | $19,948 | $-1,014 | $227,135 |
| Free Cash Flow | |||||
| Operating Cash Flow | -300,870 | -119,064 | -136,268 | -94,813 | -37,117 |
| Capital Expenditure | -7,066 | -4,228 | -2,823 | -3,740 | -1,092 |
| Free Cash Flow | -307,936 | -123,292 | -139,091 | -98,553 | -38,209 |